Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.
Jen WY, Marvin-Peek J, Kantarjian HM, Alvarado Y, Borthakur G, Jabbour E, Wierda W, Kadia TM, Daver NG, DiNardo CD, Short NJ, Jain N, Ferrajoli A, Kornblau S, Yilmaz M, Ohanian M, McCue D, Burger J, Hammond D, Patel K, Issa GC, Pemmaraju N, Sasaki K, Maiti A, Abbas HA, Chien K, Takahashi K, Haddad F, Bose P, Masarova L, Montalban-Bravo G, Swaminathan M, Brandt M, Pierce S, Garcia-Manero G, Ravandi F. Jen WY, et al. Among authors: pierce s. Cancer. 2024 Nov 25. doi: 10.1002/cncr.35662. Online ahead of print. Cancer. 2024. PMID: 39584789
Clinical study of a micro-implantable pulse generator for the treatment of peripheral neuropathic pain: 12-month results from the COMFORT-randomized controlled trial.
Hatheway J, Hersel A, Engle M, Gutierrez G, Khemlani V, Kapural L, Moore G, Ajakwe R, Trainor D, Hah J, Staats PS, Makous J, Heit G, Kottalgi S, Desai MJ; COMFORT Study Group. Hatheway J, et al. Reg Anesth Pain Med. 2024 Nov 20:rapm-2024-106099. doi: 10.1136/rapm-2024-106099. Online ahead of print. Reg Anesth Pain Med. 2024. PMID: 39572166
A phase II trial of ipilimumab, nivolumab, or ipilimumab and nivolumab with or without azacitidine in relapsed or refractory myelodysplastic neoplasms.
Bouligny IM, Montalban-Bravo G, Sasaki K, Daver N, Jabbour E, Alvarado Y, DiNardo CD, Ravandi F, Borthakur G, Pemmaraju N, Kadia T, Masarova L, Takahashi K, Andreeff M, Bazinet A, Yang H, Kanagal R, Pierce S, Meyer M, Huang X, Garcia-Manero G. Bouligny IM, et al. Among authors: pierce s. Leukemia. 2024 Nov 17. doi: 10.1038/s41375-024-02457-7. Online ahead of print. Leukemia. 2024. PMID: 39551874 No abstract available.
Causes of death in patients with myelodysplastic syndrome and spliceosome mutations.
Kontoyiannis PD, Peddireddy AS, Sasaki K, Chien K, Senapati J, Montalban-Bravo G, DiNardo C, Borthakur G, Kanagal-Shamanna R, Bueso-Ramos C, Pierce S, Kantarjian H, Garcia-Manero G, Urrutia S. Kontoyiannis PD, et al. Among authors: pierce s. Leuk Res. 2024 Dec;147:107612. doi: 10.1016/j.leukres.2024.107612. Epub 2024 Nov 6. Leuk Res. 2024. PMID: 39536685 No abstract available.
Empowered Family-Centered Care: Our Story.
Pierce LL, Smith JL, Pierce SW, Smith ER. Pierce LL, et al. Among authors: pierce sw. J Neurosci Nurs. 2024 Nov 28. doi: 10.1097/JNN.0000000000000800. Online ahead of print. J Neurosci Nurs. 2024. PMID: 39514864 No abstract available.
A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure.
Chien KS, Rodriguez-Sevilla JJ, Alvarado Y, Montalban-Bravo G, Hammond DE, Swaminathan M, Bazinet A, Kimberley J, Bodden K, Schneider H, Dong XQ, Pierce SA, Huang X, Jabbour EJ, Kantarjian HM, Garcia-Manero G. Chien KS, et al. Among authors: pierce sa. Leuk Res. 2024 Dec;147:107602. doi: 10.1016/j.leukres.2024.107602. Epub 2024 Oct 22. Leuk Res. 2024. PMID: 39461095 No abstract available.
1,406 results